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Abstract 
Conformational changes in proteins are fundamental to all biological functions. In protein 
science, the concept of protein flexibility is widely used to describe protein dynamics and 
thermodynamic properties that control protein conformational changes. In this study, we 
show that urea, which has strong sedative potency, can be administered to fish at high con-
centrations, and that protein functional changes related to anesthesia induction can be 
measured  in vivo.  Ctenopharyngodon idellus (the grass carp) has two different types of 
N-methyl d-aspartate (NMDA) receptors, urea-insensitive and urea-sensitive, which are 
responsible for the heat endurance of fish. The urea-sensitive NMDA receptor showed high 
protein flexibility, the gamma aminobutyric acid (GABA) receptor showed less flexibility, and 
the protein that is responsible for ethanol anesthesia showed the lowest flexibility. The re-
sults suggest that an increase in protein flexibility underlies the fundamental biophysical 
mechanisms of volatile general anesthetics. 
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Introduction 
The mechanism of action of volatile general an-
esthetics still remains an enigma in medical science 
and biology (1-4). By the turn of the 20th century, 
Meyer-Overton rules had proposed that volatile 
anesthetics would increase in potency as a function of 
their solubility in olive oil (1). This discovery has 
dominated our understanding of action of volatile 
anesthetics for a century, indicating an underlying 
premise that the lipid bilayer of the cell membrane is a 
primary target of volatile general anesthetics. Thus, 
changes in membrane density (critical volume 
hypothesis) and membrane fluidity were invoked as 
the mechanism of action of volatile anesthetics (1).  
However, the work of Frank and Lieb 
fundamentally changed this original attitude toward 
anesthetic function (5, 6). Their work showed that the 
target of volatile general anesthetics was protein, not 
the cell membrane. The Meyer-Overton rule could be 
also interpreted by nonspecific interactions between 
volatile general anesthetics and hydrophobic areas of 
a protein (5, 6). In recent years, a number of gene 
mutants have been isolated that code for proteins 
related to anesthetics (7, 8).   
Volatile general anesthetics can act on all 
proteins in vivo (1-3, 9). Consequently, it is necessary 
to differentiate the diversified effects of anesthesia 
induction. Theoretically speaking, the protein target 
of an anesthetic can be classified into four groups: 1) 
full target protein of anesthetics, in which the change 
of function (protein conformation) induces a full 
anesthesia state; 2) contributing protein targets of 
anesthetics, in which the change of conformation 
alone does not induce full anesthesia state, but 
contributes to the depth of the anesthesia depth and 
its effect can be seen in combined anesthesia; 3) 
complementary protein target of anesthetics, which 
do not influence the depth of anesthesia, but can 
satisfy other requirement of operation, such as muscle 
relaxation; or 4) the protein target of the anesthetic has 
nothing to do with the anesthesia effect. 
Currently, there are two different approaches for 
investigating the action mechanism of anesthetics. Int. J. Biol. Sci. 2009, 5 
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The first approach is based on the hypothesis that 
different volatile general anesthetics act on different in 
vivo protein targets (1-4, 9). The second approach 
views volatile general anesthetics as all acting on the 
same protein target and all other effects are 
independent of anesthesia depth. The underlying 
conclusion of first hypothesis is that the 
Meyer-Overton rule is nonsense and that the 
interaction between a protein target and a particular 
anesthetic is specific. In contrast, the second 
hypothesis views the interaction of protein and 
volatile general anesthetics as unspecific.  
There is evidence in support of both of these 
hypotheses. For the first hypothesis, different volatile 
general anesthetics have been shown to have different 
profiles on the activity of ion channels, the NMDA 
receptor, the GABA receptor, and a number of other 
proteins (1-8). No single protein that has been studied 
can account for all properties of action of volatile 
anesthetics (1, 4). This hypothesis recognizes that all 
volatile general anesthetics do not have to act in the 
same way.  
Evidence in support of the second hypothesis 
includes: 1) the required concentration of volatile 
general is quite high; for example, it is 0.5 mol/L for 
ethanol. Chemically speaking, the specific interaction 
between a protein and ligand normally occurs below a 
ligand concentration of 100 mmol/L. This high 
concentration of anesthetic indicates that the 
interaction between it and the target protein is 
unspecific. 2) this unspecific interaction between 
protein and volatile general anesthetics can account 
for Meyer-Overton rules; 3) changes in pressure can 
reverse the anesthetic effect (1); and 4) it is unlikely 
that the number of volatile general anesthetics can act 
on so many different proteins.  
If a volatile general anesthetic acts on proteins in 
an unspecific manner, it must be influencing the 
nature of protein dynamics (protein flexibility). A 
conformational change (or alteration of function) of 
specific proteins in the brain (or the peripheral nerv-
ous system) is the molecular mechanism underlying 
anesthesia (10, 11). Based upon the above considera-
tions and reviewing protein thermodynamic struc-
tural theory, Zhao has predicted that an increase in 
protein flexibility induced by volatile general anes-
thetics is the fundamental biophysical mechanism of 
anesthesia (12). If this is the case, we have postulated 
that urea and guanidine hydrochloride, two protein 
denaturants that are most commonly used in bio-
chemistry (13), should show anesthetic potency to 
some degree and thus should show cooperativity with 
volatile general anesthetics. Our tests have confirmed 
this prediction to be true. Because guanidine hydro-
chloride shows high toxicity even at low concentra-
tions (0.2 M) (data not shown), in this study, we have 
examined urea in more detail.  
Urea increases protein flexibility and is widely 
used in vitro to disturb protein conformation in order 
to measure this flexibility (13). However, there are 
very few reports about urea endurance of cells and 
intact fish (e.g. 14). In the current study, we show that 
fish can tolerate high concentrations of urea and that 
the flexibility of proteins related to the induction of 
anesthesia can be measured in vivo.  
Small organic solvents, such as ethanol, chloro-
form, phenol, are also known in biochemistry to be 
protein conformation disturbers or denaturants 
(15-18). Among the consideration that most volatile 
anesthetics are organic solvent with small molecular 
weight, theoretically speaking they are protein dena-
turant or protein flexibility enhancer. When protein 
flexibility is disturbed by a denaturant, the equilib-
rium between different conformational states of that 
protein can be disrupted, which may result in the al-
teration of the functional conformation of the protein 
(19, 20). Although urea and organic substances influ-
ence protein conformation through different chemical 
mechanisms, their net effects on protein conforma-
tional changes overlap. Therefore, they can act coop-
eratively in the induction of anesthesia.   
Based on the discovery that high in vivo concen-
trations of urea can be tolerated by fish, we have de-
veloped a new technique to measure in vivo protein 
functional changes. Unlike in vitro tests, in which the 
protein activity can be determined directly, we cannot 
determine protein activity (or enzyme activity) di-
rectly through in vivo m e t h o d s .  W e  c a n ,  h o w e v e r ,  
determine the behavioral changes in a fish that has 
had a protein conformational change induced. By 
analyzing the dose–response curve of a ligand for a 
protein target in the presence of urea, we can indi-
rectly measure the functional change of that protein. 
The protein flexibility, or more specifically, its sensi-
bility to urea, can then be judged.  
By applying this technique, we have been able to 
successfully measure the functional changes of several 
proteins involved in anesthesia induction. These in-
clude two types of N-methyl d-aspartate (NMDA) 
receptors (urea-sensitive and urea-insensitive) that are 
present in grass carp. None of the GABA or NMDA 
receptors appear to be full protein targets of ethanol 
anesthesia.  
The grass carp (21) was selected for use in our 
experiments because it can be obtained in vast quan-
tities in Beijing. In addition, urea can be readily re-
moved from the body of the fish, and the full recovery 
of the fish from the anesthetized state has been well Int. J. Biol. Sci. 2009, 5 
 
http://www.biolsci.org 
413
established.  
Experimental Procedures 
Materials 
Larval fish of the species Ctenopharyngodon idellus 
(grass carp, or white amur) with body weights be-
tween 2 and 5 g were purchased in the Beijing market 
(China). Beijing winter grass carp are fish caught in 
the winter in Beijing; these fish cannot endure tem-
peratures above 30℃. Beijing summer fish are those 
caught in the summer, and these fish can tolerate 
temperatures up to at least 37℃. Beijing winter grass 
carp can transform into summer grass carp when they 
are grown at 22℃ for more than 10 days.  
Methods 
Chemicals were added to the tap water in which 
the fish were kept, and the behavior of the fish was 
observed. Levels of chemicals were added at rates that 
kept their concentrations constant throughout the 
experimental period (data not shown).  
In studying the anesthetic effect of urea, several 
criteria were used to determine the level of anesthesia 
in the fish. These criteria included the loss of response 
to stimuli (mechanical and sound), loss of equilibrium 
(floating belly up), loss of the sense of direction, loss 
of muscle tone, and cessation of voluntary swimming 
(22). Fish were fasted for 12–16 hours prior to receiv-
ing anesthesia and oxygen was supplied during all 
experiments. In general, 6–10 fish were utilized in 
each experiment. For the measurement of protein 
flexibility, the endpoint of anesthesia was taken to be 
the point at which equilibrium was lost and the fish 
floated upside down; this point could be easily 
judged. During induction of anesthesia, fish typically 
had difficulty remaining upright, and finally swam on 
their sides or upside down (the fully anesthetized 
state).  
For the purposes of the experiment, the fully 
anesthetized state was required to persist for at least 5 
minutes, during which the fish could not swim up-
right. The anesthetic concentration of the drug in 
question was defined as the concentration at which all 
fish were anesthetized within 10 minutes, but could 
not be anesthetized within 6 minutes. If all fish were 
anesthetized within 6 minutes, the drug concentration 
was deemed to be too high and the test was repeated. 
The accuracy of the determination of anesthetic 
concentration was approximately 5%, and the preci-
sion (or repeatability) was approximately 2% for tests 
performed simultaneously. Because precise results 
could be consistently obtained, statistical analysis of 
data was deemed unnecessary.  
Principle of Protein Functional Change Meas-
urements 
At concentrations below 1.2 M, urea does not 
overcome physiological homeostasis, but it can in-
fluence protein function by increasing protein flexi-
bility. The urea treatment caused subtle conforma-
tional changes in numerous receptors (proteins) that 
were not detectable at the behavioral level, so we 
could not directly measure the functional change of a 
specific protein. In order to measure the functional 
change of a protein of interest, a specific ligand of this 
protein was used to strengthen its functional change, 
and thus, a change in its biological function could be 
observed at behavioral level.  
By analyzing the change of the dose–response of 
a ligand for a target protein in the presence of urea (or 
the ligand–urea titration for anesthesia in this case), 
we can indirectly measure the functional change of 
the protein. Protein flexibility can be judged from the 
slope of the ligand–urea titration during anesthesia. 
As a protein with higher flexibility will usually show 
a greater functional change at low concentrations of 
urea, the amount of ligand (drug) required for anes-
thesia induction should be less. The onset of the 
anesthetized state (the equivalence point for the 
ligand–urea titration) can be easily and precisely de-
termined, and therefore the flexibility of proteins re-
lated to anesthesia induction can be judged.  
Theoretically, a ligand such as alcohol may 
produce its measured effects through many receptors, 
rather than only through a single one. However, in 
practice, only the interaction between ethanol and a 
full protein target of ethanol anesthesia can be meas-
ured. If there is no full target for ethanol, the result 
may be very complex and the figure will not be easily 
analyzed. However, we did not encounter this type of 
case in our study. Another consideration is that many 
proteins (and receptors) of a ligand may contribute to 
the induction of anesthesia. For the same reasons, 
only a full target of a ligand involved in anesthesia 
induction can be measured. We were therefore able to 
judge the flexibility of a single protein.  
Results 
The toxicity and anesthetic potency of urea 
Because there have been no previous reports 
regarding the toxicity and anesthetic potency of urea, 
we first tested fish for sensitivity to this compound. 
The results are shown in Table 1.  
Two phases, sedation and agitation, were clearly 
observed as responses of grass carp to urea. The first 
response was the loss of sensitivity to sound and to 
vibrating stimuli; this was followed by the loss of di-Int. J. Biol. Sci. 2009, 5 
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rectional sense (fish would frequently swim into the 
walls), and finally, sensitivity to mechanical stimuli 
would be lost. The ability to maintain equilibrium was 
not fully destroyed by urea even at very high concen-
trations (e.g. 2.0 M). No effect on respiration was ob-
served in our experiments. These results clearly sug-
gest that urea has a weak anesthetic potency and it 
alone cannot induce a full anesthesia state of a fish. 
However, urea cannot be classified as a traditional 
anesthetic because of its convulsive effects.  
Table 1. The toxicity and anesthetic potency of urea. (T) 
Under this urea condition, the anesthesia test can be per-
formed within 10 minutes. (a) The safe concentration refers 
to the urea concentration at which no death of fish occurs 
within 20 minutes and at which fish continue to survive after 
removal of urea. The conditional death concentration refers 
to the urea concentration at which no death occurs within 
20 minutes but death may be seen after removal of urea, or 
fish are unable to eat. The acute death concentration refers 
to the urea concentration at which the death of fish may be 
seen within 20 minutes. (b) The convulsion potency of urea 
can be fully suppressed by ethanol, urethane, and mida-
zolam, but not by ketamine. This finding rules out the pos-
sibility that excitability of fish is induced by the osmotic 
effect of urea solution. The test temperature was 14℃.  
Urea    Classification Phase  and  biological  trait  
0-0.3 M   (T)   Sedative phase, safety concentration (a) 
(The sensitivity to stimuli is decreased. 
The fish are less active.)  
0.4-1.0 M 
 
 
 
(T)   Agitated phase, safety concentration (a) 
(The sensitivity to stimuli is greatly de-
creased. The fish move purposelessly. 
Convulsions can occasionally be seen (b]. 
The fish lose sense of direction.) 
1.1-1.4 M 
 
  
(T) 
 
Conditional death concentration (The 
fish will die over a long period, or more 
than 30 minutes.)  
1.5-3 M 
 
 
  Acute death concentration (All fish die 
within a short period. At 3 M, all fish die 
within 3 minutes. At 2.4 M, all fish die 
within 15 minutes. At 1.8 M, fish die 
within more than 10 minutes.) 
 
At high concentrations, urea showed a potential 
to cause convulsions, with the convulsions and the 
sedative effects occurring simultaneously. However, 
it was possible to study the two processes separately 
(see the following discussion and figure 1).  
High concentrations of urea could also be lethal 
to the fish. Although the mechanism leading to death 
was not studied, it is obvious that physiological ho-
meostasis can be destroyed by high concentrations of 
urea, as many biochemical processes would be ex-
pected to be disturbed.  
The osmotic effect of urea was not a factor in our 
experiments 
The osmotic effect of high concentrations of urea 
can induce specific signal transduction systems (14). 
Consequently, it was necessary to rule out the possi-
bility that the anesthetic potency of urea was induced 
by osmotic effects of the high molarity urea solution. 
It was impossible to experimentally distinguish the 
osmotic effects of urea solution from other effects of 
urea. However, the following evidence indicates that, 
although the osmotic effect occurred in vivo, it did not 
interfere with induction of anesthesia. First, the os-
motic effect took place predominantly in the region of 
the gills, as the concentration difference for urea was 
high at this site. However, no abnormalities in respi-
ration were observed, even at urea concentrations as 
high as 2.4 M. Since the urea reached the brain 
gradually, which is judged based upon the onset of 
anesthesia, the osmotic effect of urea on the nerve cell 
membranes of fish was assumed to have been very 
small and could not be maintained. Second, the 
co-addition of urea and ethanol at high concentrations 
did not induce convulsions, suggesting that the po-
tential of urea to cause convulsions does not result 
from its osmotic pressure. Third, the osmotic effect 
should disappear when the difference in urea con-
centration between the body of the fish and the me-
dium is reduced. However, the anesthesia state of the 
fish induced by urea was stable, suggesting that the 
osmotic effect of urea was unrelated to anesthesia 
production. This hypothesis was further confirmed by 
the results of the measurement of protein flexibility.  
The time scale of biological phenomena 
The time scale of biological phenomena occur-
ring during the study was measured. An example of 
such a biological phenomenon (waving the tail of fish) 
is shown in figure 1.  
When ketamine and urea were added simulta-
neously to the water, the fish became less active 
within 40 seconds. The fish then became very excited 
after 5 minutes. This indicates that approximately 5 
minutes is required for an unknown pathway of sig-
nal transduction to exert its effects. Ketamine had 
little impact on fish movement; thus, the sedative ef-
fect observed was induced by urea. This result con-
firmed that different pathways of signal transduction 
mediated the sedative and convulsive activities of 
urea. The time required for transport of the anesthetic 
from the medium to the brain of the fish varied be-
tween approximately 40 seconds and 3 minutes. The 
drug reached its equilibrium concentration in the 
body within 10 minutes. This conclusion was sup-
ported by fact that prolonging the time did not in-
crease the number of fish anesthetized.  
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Figure 1. The activity of fish. A) The activity of fish was 
measured by recording the frequency of movement; 100% 
represents fish activity in the absence of drugs (40 
turns/minute, waving tail). The solution contained 60 mg/L 
of ketamine and 0.6 M urea. The fish were Beijing summer 
grass carp. The movements of fish were counted and the 
frequencies of tail waving were calculated. Ketamine had no 
impact on movement of fish; therefore, urea was seen to 
have a strong sedation potency. The fish become very 
excited after 5 minutes and counting became impossible. 
The curve was drawn based upon experimental data as well 
as behavioral observation (simulation). 10 fish were used in 
this test.  
 
 
 
 
 
 
The NMDA receptor and the full protein target 
of ethanol anesthesia 
The above experiments cannot be used to iden-
tify the main targets of urea or those of other general 
anesthetics. One way to investigate their identity is to 
compare the flexibility of protein targets. Therefore, 
we measured the flexibility of the NMDA receptor 
(23) and the full protein target of ethanol anesthesia.  
As shown in Figure 2, urea at low concentrations 
(0.2M) could greatly amplify the effect of ketamine. In 
contrast, cooperativity between urea and ethanol only 
occurred at very high concentrations (> 1.2 M urea). 
Use of urethane gave similar results to those obtained 
with ethanol (data not shown). These results suggest 
that the NMDA receptor for ketamine shows a high 
protein flexibility, while the full protein target of 
ethanol anesthesia is more rigid.   
 
 
 
Figure 2. The anesthesia titration curve of ketamine and 
ethanol vs. urea. The normalized concentration of ketamine 
(○) or ethanol (▲) required for anesthesia production. The 
concentration of ketamine (125 mg/L) or ethanol (2% by 
volume) required for anesthesia production in the absence 
of urea was 100% (in order to analyze and compare results 
between different tests, we explored normalized concen-
tration, rather than absolute concentration). The tem-
perature was 22℃ and Beijing summer grass carp were 
used in this test. The titration tests were done at variable 
urea concentrations and the ketamine (ethanol) concen-
tration, at which the fish can be fully anesthetized, was 
measured. The urea could cooperate with ethanol in an-
esthesia induction at high concentrations; (see at 1.2 M). In 
contrast, urea inhibited NMDA receptor activity at rather 
low concentrations, e.g. 0.2 M. Each of data points was from 
one test (10 fish), and it was further ascertained once or 
more at same concentration.  
 
Urea-sensitive and urea-insensitive NMDA re-
ceptors 
Distinct sensitivity differences were seen be-
tween winter grass carp and summer grass carp in 
response to urea.  
A s  s h o w n  i n  f i g u r e  3 ,  k e t a m i n e  a n e s t h e s i a  o f  
Beijing winter carp showed a reduced sensitivity to 
urea. For Beijing summer grass carp, the concentra-
tion of ketamine required for anesthesia at 0.3 M urea 
was 50% lower than that for control test (with no 
urea). However, urea at even higher concentrations 
did not affect the concentration of ketamine required 
for anesthesia in Beijing winter grass carp (Figure 3). 
This result indicates that Beijing winter grass carp do 
not have urea-sensitive NMDA receptors, but only 
possess the urea-insensitive NMDA receptor. The 
anesthesia curves for winter and summer grass carp 
are shown in Figure 4.  Int. J. Biol. Sci. 2009, 5 
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Figure 3. The anesthesia titration of ketamine vs. urea for 
summer and winter grass carp. The concentration of 
ketamine (125 mg/L for summer and 63 mg/L for winter 
grass carp) required for anesthesia production in the ab-
sence of urea was taken as 100%. (◆) represents Beijing 
winter grass carp and (○) represents Beijing summer grass 
carp. The temperature was 22℃. The titration tests were 
done at variable urea concentrations and the ketamine 
concentration, at which the fish can be fully anesthetized, 
was measured. In contrast with summer grass carp, the 
ketamine anesthesia of winter grass carp was insensitive to 
urea. This indicated that the NMDA receptor of winter 
grass carp differed from that of summer grass carp. Each of 
data points was from one test (10 fish), and it was further 
ascertained once or more at same concentration. 
 
 
 
Figure 4. The anesthesia curve of ketamine for winter and 
summer grass carp. (●) represents Beijing winter grass carp 
and (○) represents Beijing summer grass carp. The summer 
fish were transformed from winter fish after 10 days culture 
at 22 ℃. The temperature was 22℃. The ED50 of ketamine 
for winter grass carp is 65mg/L, whereas the ED50 of 
ketamine for summer grass carp is 115mg/L. The trans-
formation from winter to summer fish was accompanied by 
substantial physiological changes and an increase in the 
concentration of ketamine required for anesthesia. Each of 
data points was from one test (10 fish), and it was further 
ascertained once or more at same concentration.  
However, our result does not indicate the precise 
reasons for this difference in NMDA receptors; thus, 
further study using in vitro experiments are still re-
quired. Because a prolonged period of at least 10 days 
is r eq uir ed t o  t ran s fo rm  a w in t er fish  t o  a  s um m er  
fish, it is evident that a substantial physiological 
change occurs in the fish during this transformation.  
NMDA receptors are temperature sensitive 
The discovery that Beijing winter grass carp do 
not possess urea-sensitive NMDA receptors implies 
that NMDA receptors play an important role in the 
heat endurance of fish. We then tested the tempera-
ture dependence of the response of Beijing grass carp 
to ketamine and ethanol anesthesia.  
 
Figure 5. The anesthetic potency of ketamine or ethanol 
for winter grass carp vs. temperature. (△) represents 
ketamine and (▲) represents ethanol. The concentration of 
ketamine (150 mg/L) or ethanol (2.6% by volume) required 
for anesthesia production at 14℃ was 100%. The titration 
tests were done at variable temperature and the ketamine 
(ethanol) concentration, at which the fish can be fully 
anesthetized, was measured. At 27 or 29 °C, the fish be-
come very excited and measurement of anesthesia became 
impossible. The ketamine concentration dropped to zero 
near 29 ℃, at this temperature heat coma state of fish could 
be found. The NMDA receptor was temperature sensitive. 
Each of the data points was from one test (10 fish), and it 
was further ascertained once or more at same concentra-
tion.  
 
 
As shown in figure 5, when the temperature was 
elevated, the anesthetic concentration of ketamine 
dropped rapidly and tended to zero at 29 ℃. The Bei-
jing summer grass carp gave a similar profile but at 
higher temperature (data not shown). This result 
shows that NMDA receptors are temperature sensi-
tive. In contrast, the full protein target of ethanol an-
esthesia was less sensitive to temperature.  Int. J. Biol. Sci. 2009, 5 
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Titration of ketamine vs. urea at a constant 
concentration of midazolam and promethazine 
Because there are no satisfactory drugs to use for 
the determination of protein flexibility related to the 
GABA receptor (24-27) or the histamine H1 and H2 
receptors (28, 29), the protein flexibility of these re-
ceptors cannot be measured directly. Accordingly, we 
explored the technique of balanced anesthesia. Pro-
methazine (a ligand of the H1 and H2 receptors) and 
midazolam (a powerful agonist of the GABAA recep-
tor) can cooperate with ketamine in anesthesia pro-
duction. Titration of ketamine against urea was per-
formed at a constant concentration of midazolam or 
promethazine. These results are shown in figure 6.  
 
 
Figure 6. Balanced anesthesia titration (ketamine vs. urea). 
The 100% concentration represents 38 mg/L of ketamine. (
◆) represents promethazine (6.3 mg/L in all tests) and (▲) 
represents midazolam (5 mg/L in all tests). The titration 
tests were done at variable urea concentration and the 
ketamine concentration, at which the fish can be fully 
anesthetized, was measured. Beijing winter grass carp were 
selected because they lack the urea-sensitive NMDA re-
ceptor. Therefore, the alteration of the anesthetic con-
centration of ketamine reflects the alteration of GABA (or 
H1 and H2) receptor activity (or its flexibility) induced by 
urea, but not NMDA receptor. The temperature was 22℃. 
In this figure, the GABA receptor activity is biphasic. At 
urea concentrations below 0.6 mol/L, the protein flexibility 
was increased and GABA receptor activity rose. At high 
concentrations of urea, protein denaturation occurred and 
the GABA receptor gradually lost its activity. A similar 
phenomenon can be seen with many enzymes (e.g., 30). 
Each of data points was from one test (10 fish), and it was 
further ascertained once or more at same concentration. 
 
As NMDA receptors of winter fish are insensi-
tive to urea, the change in the concentration of keta-
mine required for anesthesia production reflects the 
alteration in the activity of the GABA receptor (or the 
H1 and H2 receptors) induced by urea. The results 
show that urea slightly antagonizes the effect of pro-
methazine. At a concentration of 0.1 M, urea slightly 
lessened the effect of midazolam, but at 0.3–0.6 M, 
urea greatly strengthened the effect of midazolam. 
This indicates that GABA receptor activity was 
greatly influenced by concentrations of 0.3–0.6 M 
urea.  
Conclusion and discussion 
The observed effect of urea is induced by in-
creasing protein flexibility of a target receptor 
According to well-established knowledge of 
biochemistry, the urea-protein interaction can be 
analyzed by two different mechanisms. The first is 
specific interaction between protein and urea which 
occurs at urea concentration below 0.1 M, within this 
mechanism the urea acts a ligand of a protein. The 
second is unspecific interaction between urea and 
protein, which occurs at urea concentration above 0.1 
M, within this mechanism the urea acts molecules of 
solvent. The protein functional changes we measured 
in our tests were at urea concentrations of 0.1 M to 1.2 
M, therefore the effect of urea is to increase protein 
flexibility (15-18). We use a broad sense of the concept 
of protein conformational change here, which would 
include protein denaturation, alteration of 
ligand-receptor (or drug) binding constants (30, 31), 
and dissociation or rearrangement of protein com-
plexes (32).   
It can be argued that there are undoubtedly a 
huge number of biological consequences following 
the addition of urea to a fish environment. To affirm 
our contention that anesthesia state is induced by in-
creasing protein flexibility of desired receptor, we 
point out that:  
1. The time scale of anesthesia induction (1 min-
ute), which is the time required for drug conveyance 
from solution to the fish brain (see figure 1), indicates 
that anesthesia is induced by direct alteration of pro-
tein functional conformation, otherwise, the time re-
quired for anesthesia induction would be longer, 
perhaps as long as 4 minutes.  
2. Only the co-effect (desired effect) of a 
urea-receptor-ligand can induce the full state of an-
esthesia and the observed behavioral change.  
3. If an undesired effect of other receptors were 
substantially taking place, this would have disturbed 
the experimental measurements. However, an unde-
sired effect will show similar profiles in different tests. 
The figures we obtained differed greatly from each 
other, so we concluded that the undesired effect must 
be very small and it did not influence our judgment.  
4. The different effects of urea on different re-
ceptors (or proteins) could be separately measured 
(Figure 2-6).  Int. J. Biol. Sci. 2009, 5 
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These facts rule out many possible explanations 
for our test, such as disturbing the physiological state 
of fish (disturbing the equilibrium of biochemical 
networks, distribution of soluble biomaterials, etc.), 
altering cell permeability to ions and soluble com-
pounds, or reducing binding constants due to changes 
in the ionic environment.  
Ethanol at low concentration, such as 100 
mmol/L, has a great impact on the in vivo function of 
many proteins, such as the NMDA receptor (33, 34), 
the GABA receptor (35, 36), kinases (37), and signal 
transduction activities (38-41). However, these effects 
are not detectable at the behavioral level (see figure 2), 
as the anesthesia concentration of ethanol is about 0.5 
mol/L. This result indicates that the protein confor-
mational change of the full protein target (as yet un-
known) for ethanol anesthesia occurs at 0.5 M of 
ethanol. Therefore, the NMDA receptor and GABA 
receptor are not the full protein target of ethanol an-
esthesia. The NMDA receptor, as well as GABA re-
ceptor, are also not coupled to the full protein target 
of ethanol in anesthesia induction.   
Ketamine is a ligand of many ion channels, in-
cluding the NMDA receptor, nicotinic acetylcholine 
receptors (42), 5HT3 receptors (43), voltage-gated so-
dium channels (44) and the GABA receptor (45). It 
should be only cautiously asserted that the behavioral 
changes in fish are induced by the NMDA receptor 
and not other proteins. It is well-established that the 
NMDA receptor is a major excitatory receptor and it is 
the full protein target of ketamine anesthesia (1). 
Therefore, although ketamine can influence the func-
tions of many proteins, it is reasonable to conclude 
that behavioral changes in fish are mainly induced by 
functional changes of the NMDA receptor.  
Generally speaking, unless we know the essen-
tial background of ligand-receptor interaction, the 
explanation of behavioral change is very tenuous and 
we should be very cautious in explaining these data.  
An increase in protein flexibility contributes to 
the mechanism of action of volatile general an-
esthetics 
The discovery of the anesthetic potency of urea is 
significant for our understanding of the mechanism of 
action of volatile general anesthetics. It provides 
powerful evidence for the hypothesis that protein 
flexibility underlies the fundamental mechanism of 
anesthesia.  
An increase in protein flexibility could result in 
many types of changes within a protein, such as a 
protein conformational change (46, 47), a decrease of 
protein conformational coupling between sensor and 
effector of a receptor (48), and dissociation or rear-
rangement of protein complexes. These changes can 
trigger signal transduction activity and influence 
many biological functions (38, 49). Urea and volatile 
general anesthetics are all enhancers of protein flexi-
bility. Urea is weakly anesthetic and amphiphilic; its 
denaturing effect does not target hydrophobic sites 
only, but acts on all parts of a protein molecule. Vola-
tile anesthetics are strong anesthetics and are targeted 
to only the hydrophobic sites of a protein. Therefore, 
we conclude that an increase of flexibility in the hy-
drophobic sites of proteins contributes to anesthesia 
production.  
The GABA and NMDA receptors are not the full 
protein targets of ethanol anesthesia  
There are many types of NMDA and GABA re-
ceptors (23-27). The particular type of receptor that is 
responsible for anesthesia was not investigated in this 
study. The full protein target of ethanol anesthesia is 
rigid, while the urea-sensitive NMDA and GABA 
receptors show high flexibility. Therefore, the GABA 
and NMDA receptors are not the full protein targets 
of ethanol anesthesia, although volatile general anes-
thetics have a major impact on their activities (1). Both 
GABA and NMDA receptors are flexible. Urea en-
hances the activity of GABA receptors (at a concen-
tration of 0.2–0.5 M) and suppresses activity of the 
NMDA receptor. This is in agreement with the 
physiological functions of these receptors. As proteins 
show high flexibility at high temperatures, when most 
nerve cell receptors are easily excited, the requirement 
for NMDA receptor activity decreases and the re-
quirement for GABA increases. The loss of NMDA 
receptor activity that is induced by high temperature 
results in heat coma, not anesthesia.  
The opposite effect of NMDA and GBAB recep-
tor activity on stimulus could be seen in many volatile 
anesthetics (1), such as ethanol (33-37), nitrous oxide 
(50, 51), and Xenon (50, 51). The protein flexibility of 
receptors can account for these phenomena.  
The NMDA receptors play an important role in 
heat endurance of fish 
Our studies demonstrate that NMDA receptors 
have the lowest heat stability. Heat coma in fish was 
accompanied by the loss of NMDA receptor function 
(Figure 5). If fish heat coma is not fully induced by the 
NMDA receptor, the receptor must at least play an 
important role in the phenomenon. The other evi-
dence is that different types of NMDA receptors have 
been observed to act during adaptation to high tem-
peratures. Heat coma in humans may be induced by 
the same mechanism, but further study of this syn-
drome is required.  
Our results clearly show that in vivo administra-Int. J. Biol. Sci. 2009, 5 
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tion of urea can have a major impact on biological 
function, and that this can be explored experimen-
tally. The technique described in this paper is appli-
cable to many research fields.   
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